These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 34874370)
21. Fabrication of dual stimuli-responsive multicompartmental drug carriers for tumor-selective drug release. Kim HU; Choi DG; Lee H; Shim MS; Bong KW Lab Chip; 2018 Feb; 18(5):754-764. PubMed ID: 29387861 [TBL] [Abstract][Full Text] [Related]
22. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy. Wang X; Zhang M; Zhang L; Li L; Li S; Wang C; Su Z; Yuan Y; Pan W Chemistry; 2017 May; 23(27):6586-6595. PubMed ID: 28218434 [TBL] [Abstract][Full Text] [Related]
23. Current advances in lanthanide ion (Ln(3+))-based upconversion nanomaterials for drug delivery. Yang D; Ma P; Hou Z; Cheng Z; Li C; Lin J Chem Soc Rev; 2015 Mar; 44(6):1416-48. PubMed ID: 24988288 [TBL] [Abstract][Full Text] [Related]
24. Magnetism, Ultrasound, and Light-Stimulated Mesoporous Silica Nanocarriers for Theranostics and Beyond. Lin FC; Xie Y; Deng T; Zink JI J Am Chem Soc; 2021 Apr; 143(16):6025-6036. PubMed ID: 33857372 [TBL] [Abstract][Full Text] [Related]
25. Biodegradation and Toxicity of Protease/Redox/pH Stimuli-Responsive PEGlated PMAA Nanohydrogels for Targeting Drug delivery. Jin S; Wan J; Meng L; Huang X; Guo J; Liu L; Wang C ACS Appl Mater Interfaces; 2015 Sep; 7(35):19843-52. PubMed ID: 26288386 [TBL] [Abstract][Full Text] [Related]
26. Stimuli-Responsive Drug Delivery Systems for the Diagnosis and Therapy of Lung Cancer. Lin X; Wu J; Liu Y; Lin N; Hu J; Zhang B Molecules; 2022 Jan; 27(3):. PubMed ID: 35164213 [TBL] [Abstract][Full Text] [Related]
27. High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy. Peng N; Wu B; Wang L; He W; Ai Z; Zhang X; Wang Y; Fan L; Ye Q Biomater Sci; 2016 Nov; 4(12):1802-1813. PubMed ID: 27792228 [TBL] [Abstract][Full Text] [Related]
28. Dual Stimuli-Responsive Nanoparticles for Controlled Release of Anticancer and Anti-inflammatory Drugs Combination. Feng L; Wang Y; Luo Z; Huang Z; Zhang Y; Guo K; Ye D Chemistry; 2017 Jul; 23(39):9397-9406. PubMed ID: 28489292 [TBL] [Abstract][Full Text] [Related]
29. Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution. Baeza A; Manzano M; Colilla M; Vallet-Regí M Biomater Sci; 2016 May; 4(5):803-13. PubMed ID: 26902682 [TBL] [Abstract][Full Text] [Related]
30. Visible Light and pH Responsive Polymer-Coated Mesoporous Silica Nanohybrids for Controlled Release. Wang G; Dong J; Yuan T; Zhang J; Wang L; Wang H Macromol Biosci; 2016 Jul; 16(7):990-4. PubMed ID: 26938147 [TBL] [Abstract][Full Text] [Related]
31. Superparamagnetic chitosan nanocomplexes for colorectal tumor-targeted delivery of irinotecan. Wu D; Zhu L; Li Y; Wang H; Xu S; Zhang X; Wu R; Yang G Int J Pharm; 2020 Jun; 584():119394. PubMed ID: 32407940 [TBL] [Abstract][Full Text] [Related]
32. Photonic and magnetic materials for on-demand local drug delivery. Armenia I; Cuestas Ayllón C; Torres Herrero B; Bussolari F; Alfranca G; Grazú V; Martínez de la Fuente J Adv Drug Deliv Rev; 2022 Dec; 191():114584. PubMed ID: 36273514 [TBL] [Abstract][Full Text] [Related]
33. Aptamer-based ATP-responsive delivery systems for cancer diagnosis and treatment. Sameiyan E; Bagheri E; Dehghani S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM Acta Biomater; 2021 Mar; 123():110-122. PubMed ID: 33453405 [TBL] [Abstract][Full Text] [Related]
34. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy. Saravanakumar K; Hu X; Ali DM; Wang MH Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055 [TBL] [Abstract][Full Text] [Related]
35. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics. Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398 [TBL] [Abstract][Full Text] [Related]
36. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
37. Redox responsive albumin autogenic nanoparticles for the delivery of cancer drugs. Thirupathi Kumara Raja S; Prakash T; Gnanamani A Colloids Surf B Biointerfaces; 2017 Apr; 152():393-405. PubMed ID: 28157647 [TBL] [Abstract][Full Text] [Related]
38. MTX-Loaded Dual Thermoresponsive and pH-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer. Najafipour A; Gharieh A; Fassihi A; Sadeghi-Aliabadi H; Mahdavian AR Mol Pharm; 2021 Jan; 18(1):275-284. PubMed ID: 33300343 [TBL] [Abstract][Full Text] [Related]
39. Magnetic casein-CaFe K Purushothaman B; P UM; K M MSB Int J Biol Macromol; 2020 May; 151():293-304. PubMed ID: 32084471 [TBL] [Abstract][Full Text] [Related]
40. Redox-responsive nano-carriers as tumor-targeted drug delivery systems. Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]